Free Newsletter
Funds support local vaccine-making
Vietnam and other countries are in line to get their own vaccine manufacturing capabilities, thanks to PATH, the Program for Appropriate Technology in Health. The international nonprofit is receiving $8 million from HHS's Biomedical Advanced Research and Development Authority to assist in the production and clinical development of influenza vaccines, a step toward building local production capacity in developing countries. Article
More stories about vaccine manufacturing
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: